tiprankstipranks
IO Biotech (IOBTQ)
OTHER OTC:IOBTQ
US Market
IOBTQ
IO Biotech
RESEARCH TOOLSreports
Want to see IOBTQ full AI Analyst Report?

IO Biotech (IOBTQ) Stock Forecast & Price Target

465 Followers
See the Price Targets and Ratings of:

IOBTQ Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
IO
Biotech
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IOBTQ Stock 12 Month Forecast

There Are No Analyst Ratings for IOBTQ In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IOBTQ Financial Forecast

IOBTQ Earnings Forecast

Next quarter’s earnings estimate for IOBTQ is -$0.10 with a range of -$0.18 to -$0.02. The previous quarter’s EPS was -$0.13. IOBTQ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IOBTQ has Performed in-line its overall industry.
Next quarter’s earnings estimate for IOBTQ is -$0.10 with a range of -$0.18 to -$0.02. The previous quarter’s EPS was -$0.13. IOBTQ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IOBTQ has Performed in-line its overall industry.
No data currently available

IOBTQ Sales Forecast

Next quarter’s sales forecast for IOBTQ is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. IOBTQ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IOBTQ has Performed in-line its overall industry.
Next quarter’s sales forecast for IOBTQ is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. IOBTQ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IOBTQ has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on IOBTQ
Allison Bratzel
Piper Sandler
Piper Sandler
$3→$0.5
Hold
4900.00%
Upside
Downgraded
01/23/26
IO Biotech downgraded to Neutral from Overweight at Piper SandlerIO Biotech downgraded to Neutral from Overweight at Piper Sandler
Morgan Stanley Analyst forecast on IOBTQ
Michael Ulz
Morgan Stanley
Morgan Stanley
$0.39→$0.36
Sell
3500.00%
Upside
Downgraded
01/08/26
IO Biotech downgraded to Underweight from Equal Weight at Morgan StanleyIO Biotech downgraded to Underweight from Equal Weight at Morgan Stanley
H.C. Wainwright Analyst forecast on IOBTQ
Emily Bodnar
H.C. Wainwright
H.C. Wainwright
―
Hold
―
Reiterated
11/17/25
Analysts Are Neutral on Top Healthcare Stocks: Anavex Life Sciences (AVXL), IO Biotech (IOBT)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on IOBTQ
Allison Bratzel
Piper Sandler
Piper Sandler
$3→$0.5
Hold
4900.00%
Upside
Downgraded
01/23/26
IO Biotech downgraded to Neutral from Overweight at Piper SandlerIO Biotech downgraded to Neutral from Overweight at Piper Sandler
Morgan Stanley Analyst forecast on IOBTQ
Michael Ulz
Morgan Stanley
Morgan Stanley
$0.39→$0.36
Sell
3500.00%
Upside
Downgraded
01/08/26
IO Biotech downgraded to Underweight from Equal Weight at Morgan StanleyIO Biotech downgraded to Underweight from Equal Weight at Morgan Stanley
H.C. Wainwright Analyst forecast on IOBTQ
Emily Bodnar
H.C. Wainwright
H.C. Wainwright
―
Hold
―
Reiterated
11/17/25
Analysts Are Neutral on Top Healthcare Stocks: Anavex Life Sciences (AVXL), IO Biotech (IOBT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IO Biotech

3 Months
xxx
Success Rate
1/7 ratings generated profit
14%
Average Return
-21.26%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 14.29% of your transactions generating a profit, with an average return of -21.26% per trade.
1 Year
Michael UlzMorgan Stanley
Success Rate
1/7 ratings generated profit
14%
Average Return
-28.26%
Copying Michael Ulz's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -28.26% per trade.
2 Years
xxx
Success Rate
1/7 ratings generated profit
14%
Average Return
-51.31%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 14.29% of your transactions generating a profit, with an average return of -51.31% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IOBTQ Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
1
0
0
0
0
Buy
0
0
0
0
0
Hold
3
1
2
1
1
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
5
2
3
1
1
In the current month, IOBTQ has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IOBTQ average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

IOBTQ Stock Forecast FAQ

What is IOBTQ’s average 12-month price target, according to analysts?
Currently, no data Available
What is IOBTQ’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IOBTQ, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is IOBTQ a Buy, Sell or Hold?
      Currently, no data Available
      What is IO Biotech’s price target?
      Currently, no data Available
      What do analysts say about IO Biotech?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of IOBTQ?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.